Our Division is helping to set the standard in the diagnosis and care of children with rheumatic diseases. As one of the first groups in the nation to develop a program to treat children with rheumatic diseases, we serve as a major referral center for Southern California, Nevada and Arizona. Division faculty operate a busy satellite unit at Miller Children’s Hospital in Long Beach. Each year, our multidisciplinary team logs approximately 6,500 patient visits (over 5,000 outpatient visits) per year.
COMMONLY TREATED CONDITIONS
The Division treats inflammatory and non-inflammatory rheumatic diseases, including:
• Juvenile rheumatoid arthritis
• Systemic lupus erythematosus
• Dermatomyositis
• Scleroderma
• Vasculitis
In addition, the Division maintains a focused complement of clinical research, designed to realize long-term benefits for children with airway disorders.
PROGRAMS AND SERVICES
Rheumatologists often deal with diseases that mimic other diseases such as cancer and metabolic disorders.
Often we are the first stop for a diagnosis or referral for children who need care provided by our other divisions. Our services include:
• Comprehensive assessment of a chld's disorder and extent of physical disability
• Access to full radiological and laboratory testing on campus
• Psychosocial function assessment and assistance
• Child and family education and goal setting
• Development of a comprehensive treatment plan, including specialized consultative services
• Prompt management of acute crises
• Referral for financial assistance, community services, vocational rehabilitation and support
• Facilitating assistance with educational needs of our patients, helping to assist with I.E.P.
SUPPORT FOR PEDIATRIC RHEUMATOLOGY CORE
Amgen makes significant gift to create a Pediatric Rheumatology CORE at our hospital. Read More
RESEARCH EFFORTS
An active research program involves key collaborations with other medical institutions. The Division has been instrumental in the development of the international Pediatric Rheumatology Research Network, further ensuring that our patients can benefit from cutting-edge treatments as they become available. Our hospital is the national and international leader in clinical trials for cutting-edge therapies for autoimmune diseases.
Activities of our division are led by Andreas Reiff, MD. 
